Clinical Feasibility Of Transcrestal Sinus Floor Elevation In Rbh <4Mm.
Aim or purpose: Severe maxillary posterior alveolar atrophy (residual bone height [RBH] <4 mm) has traditionally been considered a contraindication for transcrestal sinus floor elevation (TSFE), limited evidence exists on the feasibility of TSFE in such extreme bone deficiency, particularly when com...
Na minha lista:
| Principais autores: | , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Elsevier
2025-10-01
|
| Serier: | International Dental Journal |
| Fag: | |
| Online adgang: | http://www.sciencedirect.com/science/article/pii/S0020653925049688 |
| Tags: |
Ingen Tags, Vær først til at tagge denne postø!
|